Wegovy is not recommended for individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Semaglutide, a medication used for weight management and type 2 diabetes, is associated with various side effects
The acylation at position 26 is the pharmacokinetic change
Limit triggers : caffeine, alcohol, very spicy foods, and sugar alcohols (sorbitol, xylitol)
An insulin syringe measures in units
Two retrospective database studies have also evaluated weight outcomes with tirzepatide in patients without T2DM, with reported weight loss of 11.9% and 12.9% after 6 months of follow-up [13, 14]